MeSH tree: C23.550.291.656
With large language models that take notes during patient visits and algorithms that identify disease, artificial intelligence has begun to prove its worth as an assistant for physicians. But a new study from Stanford Medicine ...
Apr 16, 2024
1
41
A custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to shrink liver cancer as when a patient received immunotherapy alone, a new study shows.
Apr 9, 2024
0
66
Treatment outcomes for locally advanced rectal cancer (LARC) are less favorable for Hispanic and non-Hispanic Black patients versus non-Hispanic White patients, according to a study published online Feb. 29 in JAMA Network ...
Mar 7, 2024
0
25
For adults with acute myeloid leukemia (AML), those with central nervous system (CNS) involvement have worse overall survival, according to a review published in the February issue of Leukemia Research.
Feb 21, 2024
0
27
Factors that affect medical decision-making among patients with hidradenitis suppurativa (HS) include suffering threshold, perceptions of treatment risk, treatment fatigue, understanding of the disease, and sources of information, ...
Jan 17, 2024
0
26
Researchers from Rutgers and other institutions have uncovered significant variations in how inflammatory bowel disease (IBD) affects people of different races, sexes and places of birth.
Jan 2, 2024
0
62
In a post hoc analysis of the Phase II NOBILITY trial, researchers found that treatment with obinutuzumab—an antibody that targets a protein expressed on certain immune cells—was superior to placebo for preserving kidney ...
Nov 10, 2023
0
49
Patients and their caregivers are increasingly turning to online communities, such as social media, for health information about disease and treatment. But doing so may not provide relevant or useful results, particularly ...
Sep 6, 2023
0
34
Patient-reported outcome (PRO) data are collected in oncology trials to determine patients' perspectives of cancer treatment—unfortunately often too briefly, for example only up to the point when an X-ray shows tumor growth ...
Aug 4, 2023
0
38
Younger adults with newly diagnosed multiple myeloma who receive an autologous stem cell transplant (auto-HCT) have a median progression-free survival (PFS) of approximately 3.5 years and a median overall survival (OS) of ...
Jul 27, 2023
0
47
